Market Overview

BG Medicine Appoints Charles H. Abdalian, Jr. CFO


BG Medicine (NASDAQ: BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that it has appointed Charles H. Abdalian, Jr., as the company's Executive Vice President, Chief Financial Officer. Mr. Abdalian most recently held the position of Vice President and Chief Financial Officer of Knome, Inc., a bioinformatics company providing human genome interpretation software and services to international bio/pharma companies, leading academic institutions and molecular diagnostics labs.

"We are pleased to welcome Chuck to the CFO role," said Eric Bouvier, President and Chief Executive Officer of BG Medicine, Inc. "As the Company enters its next phase of growth, Chuck brings over thirty years of experience in Healthcare corporate finance and strategic management which will provide us with key insights into successfully creating value as we advance our products in the global marketplace."

Posted-In: News Management


Related Articles (BGMD)

View Comments and Join the Discussion!

Partner Center